Skip to main content
. 2020 Jun 15:pvaa064. doi: 10.1093/ehjcvp/pvaa064

Figure 2.

Figure 2

Forest plot depicting meta-analysis of clinical severity based on Chinese guidelines in COVID-19 patients on an angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB).